- Home
- BIVI vs GNLN Comparison
BIVI vs GNLN Comparison
Compare BIVI & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- GNLN
- Stock Information
- Founded
- BIVI 2013
- GNLN 2005
- Country
- BIVI United States
- GNLN United States
- Employees
- BIVI N/A
- GNLN N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- GNLN Durable Goods
- Sector
- BIVI Health Care
- GNLN Consumer Discretionary
- Exchange
- BIVI Nasdaq
- GNLN Nasdaq
- Market Cap
- BIVI 14.2M
- GNLN 12.9M
- IPO Year
- BIVI N/A
- GNLN 2019
- Fundamental
- Price
- BIVI $1.50
- GNLN $3.03
- Analyst Decision
- BIVI
- GNLN
- Analyst Count
- BIVI 0
- GNLN 0
- Target Price
- BIVI N/A
- GNLN N/A
- AVG Volume (30 Days)
- BIVI 119.4K
- GNLN 751.5K
- Earning Date
- BIVI 11-11-2025
- GNLN 11-14-2025
- Dividend Yield
- BIVI N/A
- GNLN N/A
- EPS Growth
- BIVI N/A
- GNLN N/A
- EPS
- BIVI N/A
- GNLN N/A
- Revenue
- BIVI N/A
- GNLN $7,954,000.00
- Revenue This Year
- BIVI N/A
- GNLN $1,541.21
- Revenue Next Year
- BIVI N/A
- GNLN N/A
- P/E Ratio
- BIVI N/A
- GNLN N/A
- Revenue Growth
- BIVI N/A
- GNLN N/A
- 52 Week Low
- BIVI $1.42
- GNLN $2.75
- 52 Week High
- BIVI $38.50
- GNLN $2,737.50
- Technical
- Relative Strength Index (RSI)
- BIVI 29.30
- GNLN 38.02
- Support Level
- BIVI $1.83
- GNLN $3.06
- Resistance Level
- BIVI $1.80
- GNLN $3.29
- Average True Range (ATR)
- BIVI 0.10
- GNLN 0.25
- MACD
- BIVI -0.03
- GNLN -0.03
- Stochastic Oscillator
- BIVI 14.79
- GNLN 28.00
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.